It is a pharma public limited company based in Delhi, Delhi, India, established in 1989.
1989 | Delhi, Delhi, India | ActiveSunny Drugs And Pharmaceuticals Limited, a active public limited company, was established on 11 October 1989 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U74899DL1989PLC037985. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹8.74 M.
It upholds a compliant status. Its leadership includes Brij Kant (Director), Manohar Lal Khanna (Director), Naresh Kumar Puri (Director). Past directors included Brij Kant, Virendra Khanna. It holds ₹2.30 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1713/28Ist Floor Mangal Building No 2 Bhagirath Palace, Delhi, Delhi, 110006.
U74899DL1989PLC037985
037985
11 October 1989
₹6.00 Cr
₹8.74 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Sunny Drugs And Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Brij Kant | Director | 29 Mar 2019 | Current |
| Manohar Lal Khanna | Director | 21 Dec 1992 | Current |
| Naresh Kumar Puri | Director | 21 Dec 1992 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 27 Sep 2019 | Past |
| Pramod Abcsdd | Director | 30 Mar 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sunny Drugs And Pharmaceuticals Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 47.99% increase in profit. The company's net worth dipped by a decrease of 0.71%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Sunny Drugs And Pharmaceuticals had a promoter holding of 81.17% and a public holding of 18.83%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,300,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Jan 1994 | Bombay Mucantile Co-Op. Bank Ltd. | ₹2.30 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sunny Drugs And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sunny Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunny Drugs And Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sunny Drugs And Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Sunny Drugs And Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity Brij Kant was appointed as a Director was appointed as a Director on 29 Mar 2019 & has been associated with this company since 6 years 8 months . was completed.
A charge with Bombay Mucantile Co-Op. Bank Ltd. of Rs. 0.23 Cr registered on 14 Jan 1994 with Charge ID 90046094 was modified on 26 Sep 1995. was recorded as a recent event.
A charge with Bombay Mucantile Co-Op. Bank Ltd. amounted to Rs. 0.23 Cr with Charge ID 90046094 was registered on 14 Jan 1994. was recorded as a recent event.
The activity Manohar Lal Khanna was appointed as a Director was appointed as a Director on 21 Dec 1992 & has been associated with this company since 33 years 2 days . was completed.
The CIN of Sunny Drugs And Pharmaceuticals Limited is U74899DL1989PLC037985.
Sunny Drugs And Pharmaceuticals Limited is headquartered at 1713/28Ist Floor Mangal Building No 2 Bhagirath Palace, Delhi, Delhi, 110006.
Sunny Drugs And Pharmaceuticals Limited was incorporated on 11 October 1989.
The current directors of Sunny Drugs And Pharmaceuticals Limited are
The primary industry of Sunny Drugs And Pharmaceuticals Limited is Pharma.
Sunny Drugs And Pharmaceuticals Limited is unlisted.
The authorized capital of Sunny Drugs And Pharmaceuticals Limited is ₹6.00 Cr, and the paid-up capital is ₹8.74 M.
The compliance status of Sunny Drugs And Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX